RU93025181A - ATTENUATED COLD-ADAPTED REASSORTANT STRAIN OF THE INFLUENZA VIRUS A / 47 / LEKIN / 353/89/5 / NZN2 / FOR THE PRODUCTION OF LIVE INTRANASAL GRIPOPOUS VACCINE FOR CHILDREN - Google Patents
ATTENUATED COLD-ADAPTED REASSORTANT STRAIN OF THE INFLUENZA VIRUS A / 47 / LEKIN / 353/89/5 / NZN2 / FOR THE PRODUCTION OF LIVE INTRANASAL GRIPOPOUS VACCINE FOR CHILDRENInfo
- Publication number
- RU93025181A RU93025181A RU93025181/13A RU93025181A RU93025181A RU 93025181 A RU93025181 A RU 93025181A RU 93025181/13 A RU93025181/13 A RU 93025181/13A RU 93025181 A RU93025181 A RU 93025181A RU 93025181 A RU93025181 A RU 93025181A
- Authority
- RU
- Russia
- Prior art keywords
- strain
- children
- vaccine
- production
- genes
- Prior art date
Links
- 229960005486 vaccines Drugs 0.000 title claims 3
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 241001500351 Influenzavirus A Species 0.000 title 1
- 230000002238 attenuated Effects 0.000 title 1
- 208000006572 Human Influenza Diseases 0.000 claims 2
- 206010022000 Influenza Diseases 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 241000287828 Gallus gallus Species 0.000 claims 1
- 108010061100 Nucleoproteins Proteins 0.000 claims 1
- 102000011931 Nucleoproteins Human genes 0.000 claims 1
- 101710043164 Segment-4 Proteins 0.000 claims 1
- 101700038759 VP1 Proteins 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 101700005460 hemA Proteins 0.000 claims 1
- 230000003067 hemagglutinative Effects 0.000 claims 1
- 239000000185 hemagglutinin Substances 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 230000002458 infectious Effects 0.000 claims 1
- 230000004301 light adaptation Effects 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 238000005215 recombination Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
Claims (1)
Publications (1)
Publication Number | Publication Date |
---|---|
RU93025181A true RU93025181A (en) | 1996-01-27 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fiers et al. | M2e-based universal influenza A vaccine | |
Desheva et al. | Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential | |
Shinya et al. | Characterization of a human H5N1 influenza A virus isolated in 2003 | |
Kang et al. | Novel vaccines against influenza viruses | |
Kawaoka et al. | Evolution of the A/Chicken/Pennsylvania/83 (H5N2) influenza virus | |
Saito et al. | Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host‐cell adaptation | |
Uraki et al. | A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges | |
Qiu et al. | Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin-or neuraminidase-expressing DNA in BALB/c mice | |
Gambaryan et al. | Comparative safety, immunogenicity, and efficacy of several anti‐H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine) | |
Yang et al. | Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets | |
CN101780275A (en) | Development of H5N1 subtype avian influenza cold-adaption attenuated live vaccines and application thereof | |
Chen et al. | The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets | |
Reneer et al. | Broadly reactive H2 hemagglutinin vaccines elicit cross-reactive antibodies in ferrets preimmune to seasonal influenza a viruses | |
Wan et al. | Alternative strategy for a quadrivalent live attenuated influenza virus vaccine | |
Haque et al. | Confronting potential influenza A (H5N1) pandemic with better vaccines | |
Gibson et al. | Sequence analysis of the equine H7 influenza virus haemagglutinin gene | |
Lee et al. | Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus | |
CN102153654A (en) | Branched polypeptide using immune active peptide as vector and derivatives and application of branched polypeptide | |
RU93025181A (en) | ATTENUATED COLD-ADAPTED REASSORTANT STRAIN OF THE INFLUENZA VIRUS A / 47 / LEKIN / 353/89/5 / NZN2 / FOR THE PRODUCTION OF LIVE INTRANASAL GRIPOPOUS VACCINE FOR CHILDREN | |
Timofeeva et al. | Changes in the phenotypic properties of highly pathogenic influenza A virus of H5N1 subtype induced by N186I and N186T point mutations in hemagglutinin | |
Seo et al. | Epidemiology of influenza virus in Korean poultry | |
Huber et al. | Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus | |
RU92006474A (en) | ATTENUATED COLD-ADAPTED LENINGRAD / 14/17/55 INFLUENZA VIRUS STRAIN FOR OBTAINING LIVE INTRANASAL GRIPOPOUS VACCINE STRAINS | |
RU2078818C1 (en) | Strain a/17/peking/92/4(h3n2) for making the live influenza intranasal vaccine for adult | |
RU92006182A (en) | ATTENUATED COLD-ADAPTED INFLUENZA VIRUS A / LENINGRAD / 134/17/57 / H2N2 / STRAIN FOR OBTAINING LIVE INTRANASAL GRIPOPOUS VACCINE STRAINS |